patient self-testing

patient self-testing

Monitoring laboratory results at home to guide day-to-day decisions about health care. Examples include ambulatory blood pressure monitoring, capillary glucose monitoring, and point-of-care testing of warfarin (by measuring the prothrombin time/international normalized ratio [PT/INR] levels).
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
providers may be unaware that patient self-testing is an option for their warfarin patients.
With the launch of the new CoaguChek Vantus system this year, Roche is further enhancing the patient self-testing experience," explained Grams.
There are known benefits of patient self-testing, particularly when it comes to the management of chronic diseases like diabetes.
She added that medical device technology is soon to allow those tests that are currently used in a POC setting to be extended to the patient self-testing environment.
A variant of patient self-testing starting to catch on in the United States is patient self-management.
This good performance by patient self-testing of their international normalized ratio (INR) suggests that "home self-testing is an acceptable alternative to high-quality clinic care and may be preferable when patient access [to a clinic] is difficult," Dr.
Roche Diagnostics stated that the acquisition will allow it to expand its immunochemistry business from human diagnostics into life science research and development, patient self-testing, veterinary testing, drug discovery, drug development and clinical trials.
"Patient self-testing results can often act as early warning systems for health care professionals and have been demonstrated to help patients lower their HbA1c (hemoglobin) results.
We anticipate that more new tests will be targeted for point-of-care, home health care, and patient self-testing. Some emerging technologies include patient self-testing for prothrombin times and international normalized ratio values for monitoring warfarin therapy[12] and noninvasive and semi-invasive test devices, using skin or interstitial fluid for glucose and glycosylated hemoglobin measurements for monitoring diabetes.[13] While these new technologies will make the analytical phase of testing more accessible and less burdensome, they may present some new quality assurance challenges for interpretation of test results and patient management.
Avocet Medical received prior FDA clearances for the AvoSure(TM) PT Pro+ for healthcare professional point-of-care use and the AvoSure(TM) PT for patient self-testing. Avocet Medical is a pre-IPO company that is dedicated to bringing the same benefits of improved patient outcomes, reduced overall costs and expanded access to testing for those patients at risk of stroke that the manufacturers of blood glucose monitors brought to diabetics.
Full browser ?